hoffmann roch inc license hormon research foundat patent synthet version human growth hormon said enter into licens agreement with eli lilli and involv lilli humatrop hormon use treat dwarfism children detail licens agreement were not disclos and compani offici were unavail for comment statement from compani said lilli and roch have enter into licens agreement altern litig south san francisco base genetech inc also market genet engin human growth hormon call protropin lilli receiv approv from food and drug administr market human growth hormon earlier this year lilli spokesperson said compani has effect licens patent for hormon through hoffman laroch refus comment term licens agreement last septemb hoffman laroch and foundat su genetech feder court california alleg it product infring hoffman patent for synthet hormon reuter 